SYK
Stryker Corporation · $325.70 (-6.4%) · mkt cap $124.9B · P/E 37.7
3 hub catalysts across 3 sources · backtest → · ← Ticker Explorer
U.S. House — Congressional TradesFDA Approvals & RecallsU.S. Senate — Congressional Trades
Signal summary
Signals divergeBullish and bearish forces are in conflict here — weigh both columns.
97▼ Bear-leanconviction from hub signals
Bullish factors
- FDA approval
- 1 analyst upgrade
Bearish factors
- Congress sold (2)
- Insiders net selling (12 vs 0)
Signal mix for SYK
Which data feeds have fired on this name — hover a slice for counts.
Best strategy
2-yr backtest · by SharpeCCI Mean-Reversion has fit SYK best over 2 years (+66.8%, Sharpe 1.19). Historical/in-sample — walk-forward all 19 →
| # | Strategy | Return | Sharpe | Beats B&H |
|---|---|---|---|---|
| 1 | CCI Mean-Reversion | +66.8% | 1.19 | ✓ |
| 2 | Bollinger Bands | +44.0% | 1.15 | ✓ |
| 3 | Z-Score Mean-Reversion | +53.2% | 1.13 | ✓ |
Price — 1 year
daily closeInsider activity
0 open-market buysOfficers & directors trading their own stock (SEC Form 4). Buys are bullish; sells shown for context.
| Date | Action | Insider | Shares | Value |
|---|---|---|---|---|
| 2026-05-28 | SELL | Fletcher Robert S | 4,544 | $1.4M |
| 2026-05-26 | SELL | Stryker Ronda E | 310,000 | $96.8M |
| 2026-05-11 | SELL | Fink Mary Kathryn | 8,720 | $2.5M |
| 2026-02-05 | SELL | Stryker Ronda E | 500,000 | $181.7M |
| 2026-02-02 | SELL | Pierce James Andrew | 475 | $175K |
| 2025-11-20 | SELL | Wells Preston Wendell | 165 | $60K |
| 2025-11-14 | SELL | Berry William E Jr | 1,953 | $714K |
| 2025-11-06 | SELL | Stryker Ronda E | 520,000 | $184.6M |
| 2025-08-25 | SELL | Menon Viju S | 500 | $195K |
| 2025-08-20 | SELL | Fletcher Robert S | 1,785 | $702K |
| 2025-08-06 | SELL | Stryker Ronda E | 200,000 | $75.3M |
| 2025-05-12 | SELL | Berry William E Jr | 1,241 | $482K |
Analyst ratings
live · 3 changes| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| 2026-07-09 | Initiated | BMO Capital | Market Perform → Outperform |
| 2026-04-13 | Initiated | Leerink Partners | Outperform |
| 2025-12-19 | Upgrade | Citizens | Market Perform → Market Outperform |
Catalyst timeline
3 hub signals| Date | Source | Event | Entity | Value | |
|---|---|---|---|---|---|
| 2026-08-01 | FDA Approvals & Recalls | FDA Approval | FDA approved Adherus AutoSpray Dural Sealant; Adherus AutoSpray ET Dural — Stryker Leibinger GmbH & Co KG | approval | source ↗ |
| 2026-06-02 | U.S. House — Congressional Trades | Congress SELL | Hon. Thomas H. Kean Jr | $1,001 - $15,000 | source ↗ |
| 2026-03-27 | U.S. Senate — Congressional Trades | Congress SELL | Armstrong, Alan (Senator) | $15,001 - $50,000 | source ↗ |
Alt-Data Signal Hub · collected signals updated 2026-07-28 09:17 UTC (refreshed daily) · market & option prices are always live on load · display-only, not advice